Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- David Hyman
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
50 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hartford Hospital
Hartford, Connecticut, United States
- Smilow Cancer Hospital Care Center at Saint Francis
Hartford, Connecticut, United States
- the Hospital of Central Connecticut
New Britain, Connecticut, United States
- Florida Hospital Orlando
Orlando, Florida, United States
- University of Hawaii Cancer Center
Honolulu, Hawaii, United States
- Saint Alphonsus Cancer Care Center-Boise
Boise, Idaho, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- Sudarshan K Sharma Md Limted-Gynecologic Oncology
Hinsdale, Illinois, United States
- Indiana University/melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
- Saint Vincent Hospital and Health Care Center
Indianapolis, Indiana, United States
- Mcfarland Clinic Pc-William R Bliss Cancer Center
Ames, Iowa, United States
- Iowa Lutheran Hospital
Des Moines, Iowa, United States
- Iowa Methodist Medical Center
Des Moines, Iowa, United States
- Iowa-Wide Oncology Research Coalition Ncorp
Des Moines, Iowa, United States
- Medical Oncology and Hematology Associates-Des Moines
Des Moines, Iowa, United States
- Medical Oncology and Hematology Associates-Laurel
Des Moines, Iowa, United States
- Mercy Medical Center - Des Moines
Des Moines, Iowa, United States
- University of Iowa/holden Comprehensive Cancer Center
Iowa City, Iowa, United States
- Michigan Cancer Research Consortium Ncorp
Ann Arbor, Michigan, United States
- Saint Joseph Mercy Hospital
Ann Arbor, Michigan, United States
- Beaumont Hospital-Dearborn
Dearborn, Michigan, United States
- Saint John Hospital and Medical Center
Detroit, Michigan, United States
- Hurley Medical Center
Flint, Michigan, United States
- Genesys Regional Medical Center
Grand Blanc, Michigan, United States
- Allegiance Health
Jackson, Michigan, United States
- Sparrow Hospital
Lansing, Michigan, United States
- Saint Mary Mercy Hospital
Livonia, Michigan, United States
- Saint Joseph Mercy Oakland
Pontiac, Michigan, United States
- Lake Huron Medical Center
Port Huron, Michigan, United States
- Saint Mary'S of Michigan
Saginaw, Michigan, United States
- University of Mississippi Medical Center
Jackson, Mississippi, United States
- Cancer Research for the Ozarks Ncorp
Springfield, Missouri, United States
- Coxhealth South Hospital
Springfield, Missouri, United States
- Mercy Hospital Springfield
Springfield, Missouri, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Nebraska Methodist Hospital
Omaha, Nebraska, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Unc Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States
- Carolinas Medical Center/levine Cancer Institute
Charlotte, North Carolina, United States
- Southeast Clinical Oncology Research (scor) Consortium Ncorp
Winston-Salem, North Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2012
- Primary completion
- 31 Aug 2014
- Completion
- 11 Feb 2017
- Last update posted
- 23 Jul 2019
- Registered enrollment
- 23
- Registry id
- NCT01637961
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.